Organization
Johns Hopkins Aramco HealthCare
1 abstract
Abstract
Pathological complete response rate to anthracycline versus non−anthracycline based chemotherapy regimens in localized and regional HER2 neu positive breast cancer.Org: Johns Hopkins Aramco HealthCare, Dhahran,